PhaseBio Pharmaceuticals EBIT

EBIT of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT growth rates and interactive chart. Earnings before interest and taxes is an indicator of a company's profitability. One can calculate it as revenue minus all expenses, excluding tax and interest. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes. It is the amount of profit that a company earns before interest on debt and taxes are paid.


Highlights and Quick Summary

  • EBIT for the quarter ending March 31, 2022 was $-18.2 Million (a -43.19% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT decreased by -13.42%
  • Annual EBIT for 2021 was $-215 Million (a 26.05% increase from previous year)
  • Annual EBIT for 2020 was $-170 Million (a 86.29% increase from previous year)
  • Annual EBIT for 2019 was $-91.4 Million (a 92.82% increase from previous year)
  • Twelve month EBIT ending March 31, 2022 was $-99.9 Million (a -6.91% decrease compared to previous quarter)
  • Twelve month trailing EBIT increased by 7.27% year-over-year
Trailing EBIT for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-99.9 Million $-107 Million $-101 Million $-93.2 Million
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT of PhaseBio Pharmaceuticals

Most recent EBITof PHAS including historical data for past 10 years.

Interactive Chart of EBIT of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals EBIT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-18.23
2021 $-32.09 $-28.58 $-21.05 $-25.65 $-214.72
2020 $-25.98 $-20.49 $-24.1 $-14.29 $-170.35
2019 $-11.28 $-11.59 $-9.48 $-7.38 $-91.44
2018 $-7.66 $-5.0 $-4.11 $-2.88 $-47.42
2017 $-1.9 $-23.48
2016 $-19.0

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology